¼¼°èÀÇ ±Ù°ñ°Ý°è Äɾî¿ë µðÁöÅÐ Çコ ½ÃÀå
Digital Health for Musculoskeletal Care
»óǰÄÚµå : 1774765
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 476 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,239,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,719,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°è ±Ù°ñ°Ý°è Äɾî¿ë µðÁöÅÐ Çコ ½ÃÀåÀº 2030³â±îÁö 104¾ï ´Þ·¯¿¡ À̸¦ Àü¸Á

2024³â¿¡ 43¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ±Ù°ñ°Ý°è Äɾî¿ë µðÁöÅÐ Çコ ¼¼°è ½ÃÀåÀº 2024-2030³â°£ CAGR 16.0%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 104¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. º» º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Çϵå¿þ¾î ÄÄÆ÷³ÍÆ®´Â CAGR 14.8%¸¦ ³ªÅ¸³»°í, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 69¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼ÒÇÁÆ®¿þ¾î£¦¼­ºñ½º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£¿¡ CAGR 18.6%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 12¾ï ´Þ·¯, Áß±¹Àº CAGR 21.0%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ±Ù°ñ°Ý°è Äɾî¿ë µðÁöÅÐ Çコ ½ÃÀåÀº 2024³â¿¡ 12¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 23¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³â CAGRÀº 21.0%·Î ÃßÁ¤µË´Ï´Ù. ±âŸ ÁÖ¸ñÇØ¾ß ÇÒ Áö¿ªº° ½ÃÀåÀ¸·Î¼­´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£Áß CAGRÀº °¢°¢ 12.0%¿Í 14.3%¸¦ º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 12.7%·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù.

¼¼°è ±Ù°ñ°Ý°è °ü¸®¸¦ À§ÇÑ µðÁöÅÐ Çコ ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃßÁø ¿äÀÎ ¿ä¾à

AI¸¦ Ȱ¿ëÇÑ µðÁöÅÐ Ä¡·á´Â ¿îµ¿¼±¼ö Ä¡·á¸¦ ÀçÁ¤ÀÇÇÒ ¼ö ÀÖÀ»±î?

ÀΰøÁö´É(AI), ¿ø°Ý ¹°¸®Ä¡·á Ç÷§Æû, ¿þ¾î·¯ºí ¼¾¼­ ±â¼úÀ» Ȱ¿ëÇÏ¿© ȯÀÚÀÇ È¸º¹°ú ÅëÁõ °ü¸®¸¦ °­È­ÇÔÀ¸·Î½á ±Ù°ñ°Ý°è(MSK) Ä¡·áÀÇ µðÁöÅÐ °Ç°­Àº ºü¸£°Ô ÁøÈ­Çϰí ÀÖ½À´Ï´Ù. ¸¸¼º ¿äÅë, °üÀý¿°, Á¤Çü¿Ü°úÀû ¼Õ»ó°ú °°Àº ±Ù°ñ°Ý°è ÁúȯÀº ¿îµ¿ ´É·Â°ú »îÀÇ Áú¿¡ Àå±âÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡±â ¶§¹®¿¡ Àü ¼¼°è ÀÇ·áºñ ÁöÃâÀÇ ´ëºÎºÐÀ» Â÷ÁöÇÕ´Ï´Ù. ÇöÀç AI¸¦ Ȱ¿ëÇÑ µðÁöÅÐ Ä¡·á(DTx)°¡ °³¹ßµÇ¾î ȯÀÚ¿¡°Ô ±Ù°Å¿¡ ±â¹ÝÇÑ ¹°¸®Ä¡·á ¿îµ¿À» ¿ø°ÝÀ¸·Î ÁöµµÇÏ¿© Áø·á¼Ò ¹æ¹®¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãß°í ÀÖÀ¸¸ç, AI¿Í ÄÄÇ»ÅÍ ºñÀüÀ» ÅëÇÑ Ã·´Ü µ¿ÀÛ ÃßÀû ½Ã½ºÅÛÀº µ¿ÀÛ ÆÐÅÏÀÇ Á¤È®ÇÑ Æò°¡°¡ °¡´ÉÇÕ´Ï´Ù. Á¤È®ÇÑ Æò°¡°¡ °¡´ÉÇÏ¿© ¹°¸®Ä¡·á»ç°¡ º¸´Ù È¿°úÀûÀ¸·Î ÀçȰ ÇÁ·Î±×·¥À» Á¶Á¤ÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °¡»óÇö½Ç(VR)À» ÀÌ¿ëÇÑ ÀçȰġ·á´Â ȯÀÚÀÇ Ä¡·á Âü¿©µµ¿Í Áö¼Ó¼ºÀ» ³ôÀ̱â À§ÇØ ¿¬±¸µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÌ·¯ÇÑ ±â¼ú Çõ½Å¿¡µµ ºÒ±¸Çϰí, ÀÓ»óÀû °ËÁõ È®º¸, »óȯ Á¤Ã¥ È®º¸, Àú¼Òµæ Áö¿ªÀÇ Á¢±Ù¼º ¹®Á¦ ÇØ°á µîÀÇ °úÁ¦´Â ¿©ÀüÈ÷ Áß¿äÇÑ Àå¾Ö¹°ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±×·³¿¡µµ ºÒ±¸Çϰí AI¸¦ Ȱ¿ëÇÑ ¿îµ¿Ä¡·á´Â ¹°¸®Ä¡·á¸¦ º¸´Ù µ¥ÀÌÅÍ Áß½ÉÀûÀ̰í, Æí¸®Çϰí, °á°ú Áß½ÉÀûÀ¸·Î ¸¸µé¾î Ä¡·áÀÇ Àü¸ÁÀ» º¯È­½Ãų Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

¿þ¾î·¯ºí°ú ¿ø°Ý ¸ð´ÏÅ͸µÀº MSK ÀçȰÀÇ ¹Ì·¡Àΰ¡?

¿þ¾î·¯ºí ±â¼úÀº ¿îµ¿ ÆÐÅÏ, °üÀý ¾ÈÁ¤¼º, ±ÙÀ° Ȱµ¿ÀÇ Áö¼ÓÀûÀÎ ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ¿îµ¿ ÀçȰ¿¡ Çõ¸íÀ» ºÒ·¯ÀÏÀ¸Å°°í ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À¼¾¼­, ±ÙÀüµµ(EMG) ÃßÀû±â, ¿Ü°ñ°Ý°ú °°Àº ½º¸¶Æ® ¿þ¾î·¯ºíÀº ½Ç½Ã°£ À̵¿¼ºÀ» Æò°¡ÇÏ°í ±Ù°ñ°Ý°è ±â´É Àå¾ÖÀÇ Ãʱâ ¡Èĸ¦ °¨ÁöÇÏ´Â µ¥ »ç¿ëµÇ°í ÀÖÀ¸¸ç, AI ºÐ¼®°ú ÅëÇÕµÈ ¿ø°Ý ¸ð´ÏÅ͸µ Ç÷§ÆûÀ» ÅëÇØ ÀÓ»óÀǴ ȯÀÚÀÇ °æ°ú¸¦ ÃßÀûÇϰí, Ä¡·á ¿ä¹ýÀ» µ¿ÀûÀ¸·Î Á¶Á¤ÇÒ ¼ö ÀÖ½À´Ï´Ù. Ä¡·á ¿ä¹ýÀ» µ¿ÀûÀ¸·Î Á¶Á¤Çϰí ÀÚ¼¼ ±³Á¤¿¡ ´ëÇÑ Çǵå¹éÀ» ½Ç½Ã°£À¸·Î Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿þ¾î·¯ºí ±â±â¿¡¼­ ÃßÃâÇÑ µðÁöÅÐ ¹ÙÀÌ¿À¸¶Ä¿´Â MSK HealthÀÇ ¿¹Ãø ºÐ¼®À» °­È­ÇÏ¿© Áõ»óÀÌ ¾ÇÈ­µÇ±â Àü¿¡ Á¶±â¿¡ °³ÀÔÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ¶ÇÇÑ, µðÁöÅÐ ¹°¸®Ä¡·á ¿ëµµ¿¡ ³»ÀåµÈ °ÔÀÓÈ­ ¿ä¼Ò´Â ÀçȰ ¿îµ¿À» ÀÎÅÍ·¢Æ¼ºêÇÏ°í µµÀüÀûÀÎ ¿îµ¿À¸·Î ¸¸µé¾î ȯÀÚÀÇ Âü¿©¸¦ Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. À¯¸ÁÇÑ ¹ßÀü¿¡µµ ºÒ±¸Çϰí, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã, ±â±â °¡°Ý, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ ÀýÂ÷¿¡ ´ëÇÑ ¿ì·Á·Î ÀÎÇØ º¸±Þ¿¡ ¾î·Á¿òÀ» °Þ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ¿þ¾î·¯ºí ±â¼úÀÇ Á¤È®µµ¿Í °¡°ÝÀÌ Áö¼ÓÀûÀ¸·Î °³¼±µÈ´Ù¸é, ¿îµ¿ Ä¡·á¿¡¼­ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ¼öÇàÇÏ¿© º´¿ø ¹æ¹®¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãß°í ȯÀÚÀÇ Àå±âÀûÀÎ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖÀ» °ÍÀ¸·Î ±â´ëµË´Ï´Ù.

µðÁöÅÐ Çコ´Â MSK ÅëÁõ °ü¸®¸¦ ¾î¶»°Ô °³ÀÎÈ­ÇÒ ¼ö ÀÖÀ»±î?

AI, ¸ð¹ÙÀÏ °Ç°­ ¿ëµµ, ¿ø°Ý ÀÇ·á »ó´ãÀ» Ȱ¿ëÇÑ µðÁöÅÐ °Ç°­ °³ÀÔÀ» ÅëÇØ ¿îµ¿ ÁúȯÀÇ ÅëÁõ °ü¸®°¡ Á¡Á¡ ´õ °³ÀÎÈ­µÇ°í ÀÖÀ¸¸ç, AI ±â¹Ý ÅëÁõ Æò°¡ µµ±¸´Â ȯÀÚ°¡ º¸°íÇÑ Áõ»ó, ¿îµ¿ µ¥ÀÌÅÍ, »ý¸®Àû ½ÅÈ£¸¦ ºÐ¼®ÇÏ¿© ¸ÂÃãÇü Ä¡·á °èȹÀ» ÃßõÇÔÀ¸·Î½á ¿ÀÇÇ¿ÀÀÌµå ±â¹Ý ¾à¹°¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãâ ¼ö ÀÖ½À´Ï´Ù. ¸ÂÃãÇü Ä¡·á °èȹÀ» ÃßõÇÔÀ¸·Î½á ¿ÀÇÇ¿ÀÀÌµå ±â¹Ý ¾à¹°¿¡ ´ëÇÑ ÀÇÁ¸µµ¸¦ ³·Ãß°í ÀÖ½À´Ï´Ù. ¿ø°Ý ÀçȰ Ç÷§ÆûÀº ¹°¸®Ä¡·á»ç, Ä«ÀÌ·ÎÇÁ·¢ÅÍ, ÅëÁõ Àü¹®°¡¿ÍÀÇ ¿ø°Ý »ó´ãÀ» ÅëÇØ ¼ö¼úÀ̳ª ºÎ»ó¿¡¼­ ȸº¹ ÁßÀΠȯÀÚÀÇ Áö¼ÓÀûÀÎ Ä¡·á¸¦ º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ, ¼¶À¯±ÙÀ°ÅëÀ̳ª °ñ°üÀý¿°°ú °°Àº Áõ»ó¿¡ ´ëÇØ ºñħ½ÀÀûÀÎ ÅëÁõ ¿ÏÈ­¸¦ Á¦°øÇϱâ À§ÇØ ¸ð¹ÙÀÏ ¾ÛÀ¸·Î Á¦¾îµÇ´Â ½Å°æ Á¶Àý ÀåÄ¡°¡ ¿¬±¸µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µðÁöÅÐ ÅëÁõ °ü¸® ÇÁ·Î±×·¥¿¡ ÀÎÁöÇൿġ·á(CBT) ¸ðµâÀ» ÅëÇÕÇÏ¿© ¸¸¼º ÅëÁõÀÇ ½É¸®Àû Ãø¸éÀ» ´Ù·ç´Â È¿°úµµ ÀÔÁõµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ±ÔÁ¦ Áؼö¿Í º¸Çè Àû¿ëÀ» È®º¸ÇÏ´Â °ÍÀº ¿©ÀüÈ÷ Áß¿äÇÑ °úÁ¦·Î ³²¾Æ ÀÖ½À´Ï´Ù. ´õ ¸¹Àº ÀÓ»ó½ÃÇèÀÌ µðÁöÅÐ ÅëÁõ °ü¸® ¼Ö·ç¼ÇÀ» °ËÁõÇÔ¿¡ µû¶ó, µðÁöÅÐ ÅëÁõ °ü¸® ¼Ö·ç¼ÇÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí MSK Äɾî´Â º¸´Ù ÃÑüÀûÀÌ°í ºñħ½ÀÀûÀÌ¸ç µ¥ÀÌÅÍ ±â¹ÝÀÇ Ä¡·á Á¢±Ù ¹æ½ÄÀ¸·Î ÀüȯµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

±Ù°ñ°Ý°è °ü¸®¸¦ À§ÇÑ µðÁöÅÐ Çコ ½ÃÀåÀÇ ¼ºÀå ¿øµ¿·ÂÀº?

±Ù°ñ°Ý°è Ä¡·á¸¦ À§ÇÑ µðÁöÅÐ Çコ ½ÃÀåÀÇ ¼ºÀåÀº MSK ÁúȯÀÇ À¯º´·ü Áõ°¡, ¿þ¾î·¯ºí ÀçȰ ±â±âÀÇ Ã¤Åà Áõ°¡, AI¸¦ Ȱ¿ëÇÑ ¿ø°Ý ¹°¸®Ä¡·áÀÇ ¹ßÀü µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ºñħ½ÀÀûÀÌ°í ¿ÀÇÇ¿ÀÀ̵带 »ç¿ëÇÏÁö ¾Ê´Â ÅëÁõ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ ÀÇ·á ¼­ºñ½º Á¦°ø¾÷üÀÇ µðÁöÅÐ Ä¡·á ¹× AI ±â¹Ý MSK Ä¡·á ÇÁ·Î±×·¥ äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¿ø°Ý ÀÇ·á ¼­ºñ½ºÀÇ È®´ë¿¡ ÈûÀÔ¾î ÀçÅà ÀçȰ Ä¡·á·ÎÀÇ ÀüȯÀÌ ½ÃÀå ¼ºÀåÀ» ´õ¿í °¡¼ÓÈ­Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, µðÁöÅÐ ¹°¸®Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ±ÔÁ¦Àû Áö¿ø°ú ¿ø°Ý MSK Ä¡·á¿¡ ´ëÇÑ º¸Çè Àû¿ë Áõ°¡µµ äÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Áõ°­Çö½Ç(AR)°ú °¡»óÇö½Ç(VR)À» ¹°¸®Ä¡·á¿¡ ÅëÇÕÇÏ¿© ȯÀÚÀÇ Âü¿©¸¦ ³ôÀ̰í ÀçȰÀ» º¸´Ù ÀÎÅÍ·¢Æ¼ºêÇϰí È¿°úÀûÀ¸·Î ¸¸µé°í ÀÖ½À´Ï´Ù. µðÁöÅÐ MSK ÀÇ·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÅõÀÚ°¡ °è¼Ó È®´ëµÊ¿¡ µû¶ó ½ÃÀåÀº Å©°Ô ¼ºÀåÇÏ¿© Á¤Çü¿Ü°ú ÀÇ·á, ÀçȰ ¹× ¸¸¼º ÅëÁõ °ü¸®ÀÇ ¹Ì·¡¸¦ º¯È­½Ãų °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÎ¹®

±¸¼º ¿ä¼Ò (Çϵå¿þ¾î ±¸¼º ¿ä¼Ò, ¼ÒÇÁÆ®¿þ¾î ¹× ¼­ºñ½º); ¼Ö·ç¼Ç (¿Â¶óÀÎ / °¡»ó »ó´ã ¼Ö·ç¼Ç, ÅëÁõ °ü¸® Ä¡·á ÇÁ·Î±×·¥ ¼Ö·ç¼Ç, ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç, ±âŸ ¼Ö·ç¼Ç); »óÅ (¿äÅë, ¹ß ¹× ¹ß¸ñ ÅëÁõ, ¹«¸­ ¹× ´Ù¸® ÅëÁõ, ¸ñ ¹× ¾î±ú ÅëÁõ, °ñ¹Ý, ¾ûµ¢ÀÌ ¹× Çã¹÷Áö ÅëÁõ, ±âŸ »óÅÂ); ÃÖÁ¾ »ç¿ë (ȯÀÚ ÃÖÁ¾ »ç¿ë, Á¦°øÀÚ ÃÖÁ¾ »ç¿ë, ÁöºÒÀÚ ÃÖÁ¾ »ç¿ë, ±âŸ ÃÖÁ¾ »ç¿ë).

Á¶»ç ´ë»ó ±â¾÷ ¿¹

AI ÅëÇÕ

Global Industry Analysts´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AIÅø¿¡ ÀÇÇØ¼­, ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÍ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Digital Health for Musculoskeletal Care Market to Reach US$10.4 Billion by 2030

The global market for Digital Health for Musculoskeletal Care estimated at US$4.3 Billion in the year 2024, is expected to reach US$10.4 Billion by 2030, growing at a CAGR of 16.0% over the analysis period 2024-2030. Hardware Component, one of the segments analyzed in the report, is expected to record a 14.8% CAGR and reach US$6.9 Billion by the end of the analysis period. Growth in the Software & Services segment is estimated at 18.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.2 Billion While China is Forecast to Grow at 21.0% CAGR

The Digital Health for Musculoskeletal Care market in the U.S. is estimated at US$1.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 21.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 14.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.7% CAGR.

Global Digital Health for Musculoskeletal Care Market - Key Trends & Drivers Summarized

Can AI-Powered Digital Therapies Redefine Musculoskeletal Care?

The digital health landscape for musculoskeletal (MSK) care is evolving rapidly, leveraging artificial intelligence (AI), remote physiotherapy platforms, and wearable sensor technologies to enhance patient recovery and pain management. Musculoskeletal disorders, including chronic back pain, arthritis, and orthopedic injuries, account for a significant portion of global healthcare costs due to their long-term impact on mobility and quality of life. AI-driven digital therapeutics (DTx) are now being developed to guide patients through evidence-based physical therapy exercises remotely, reducing dependency on in-clinic visits. Advanced motion-tracking systems powered by AI and computer vision allow for precise assessment of movement patterns, helping physiotherapists tailor rehabilitation programs more effectively. Additionally, virtual reality (VR)-assisted rehabilitation is being explored to improve patient engagement and adherence to therapy. However, despite these innovations, challenges such as ensuring clinical validation, securing reimbursement policies, and addressing accessibility concerns in lower-income regions remain key hurdles. Nevertheless, AI-driven musculoskeletal care is poised to transform the treatment landscape by making physical therapy more data-driven, convenient, and outcome-focused.

Are Wearables and Remote Monitoring the Future of MSK Rehabilitation?

Wearable technology is revolutionizing musculoskeletal rehabilitation by enabling continuous monitoring of movement patterns, joint stability, and muscle activity. Smart wearables such as biosensors, electromyography (EMG) trackers, and exoskeletons are now being used to assess real-time mobility and detect early signs of musculoskeletal dysfunction. Remote monitoring platforms integrated with AI analytics allow clinicians to track patient progress, adjust therapy regimens dynamically, and provide real-time feedback on posture correction. Digital biomarkers extracted from wearable devices are also enhancing predictive analytics in MSK health, enabling early interventions before symptoms worsen. Additionally, gamification elements embedded in digital physiotherapy applications are improving patient engagement by making rehabilitation exercises interactive and rewarding. Despite the promising advancements, widespread adoption is hindered by concerns over data privacy, device affordability, and regulatory approval processes. However, as wearable technologies continue to improve in accuracy and affordability, they are expected to play a pivotal role in musculoskeletal care, reducing dependency on hospital visits and improving long-term patient outcomes.

How Is Digital Health Making MSK Pain Management More Personalized?

Pain management for musculoskeletal disorders is becoming increasingly personalized through digital health interventions that leverage AI, mobile health applications, and telehealth consultations. AI-powered pain assessment tools analyze patient-reported symptoms, movement data, and physiological signals to recommend tailored treatment plans, reducing reliance on opioid-based medications. Tele-rehabilitation platforms are enabling remote consultations with physiotherapists, chiropractors, and pain specialists, ensuring continuous care for patients recovering from surgeries or injuries. Additionally, neuromodulation devices controlled via mobile apps are being explored to provide non-invasive pain relief for conditions like fibromyalgia and osteoarthritis. The integration of cognitive behavioral therapy (CBT) modules in digital pain management programs is also proving effective in addressing the psychological aspects of chronic pain. However, ensuring regulatory compliance and achieving widespread insurance coverage remain critical challenges. As more clinical trials validate digital pain management solutions, their adoption is expected to rise, shifting MSK care towards more holistic, non-invasive, and data-driven treatment approaches.

What Is Driving the Growth of the Digital Health for Musculoskeletal Care Market?

The growth in the digital health for musculoskeletal care market is driven by several factors, including the rising prevalence of MSK disorders, increasing adoption of wearable rehabilitation devices, and advancements in AI-driven remote physiotherapy. The demand for non-invasive, opioid-free pain management solutions is pushing healthcare providers to adopt digital therapeutics and AI-powered MSK treatment programs. The shift towards home-based rehabilitation, fueled by the expansion of telehealth services, is further accelerating market growth. Regulatory support for digital physiotherapy solutions and increasing insurance coverage for remote MSK care are also driving adoption. Additionally, the integration of augmented reality (AR) and virtual reality (VR) in physical therapy is enhancing patient engagement, making rehabilitation more interactive and effective. As investments in digital MSK health solutions continue to grow, the market is expected to expand significantly, transforming the future of orthopedic care, rehabilitation, and chronic pain management.

SCOPE OF STUDY:

The report analyzes the Digital Health for Musculoskeletal Care market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Hardware Component, Software & Services); Solution (Online / Virtual Consultations Solution, Pain Management Therapy Programs Solution, Remote Monitoring Solution, Other Solutions); Condition (Back Pain, Foot & Ankle Pain, Knee & Lower Leg Pain, Neck & Shoulder Pain, Pelvis, Hip & Thigh Pain, Other Conditions); End-Use (Patients End-Use, Providers End-Use, Payers End-Use, Other End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â